Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 2/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13583967 | 1.00 | HDAC3 (0.47) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL16774671 | 1.00 | HDAC3 (0.47) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL10966466 | 0.93 | HDAC3 (0.49) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL15809672 | 0.92 | ESR1 (0.39) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL1170413 | 0.89 | HDAC3 (0.50) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL8514707 | 0.86 | CA12 (0.52) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL21826727 | 0.84 | NOS1 (0.41) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL5575000 | 0.81 | HDAC3 (0.52) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL18717251 | 0.81 | MEN1 (0.41) | CA12CA1CA2CA9EPHX2 | |
| SCHEMBL161188 | 0.80 | CA12 (0.65) | HDAC3HDAC4HDAC1HDAC7HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2443482-B1 | BIOMEDICAL DEVICES, POLYMERIC MATERIALS AND CONTACT LENSES COMPRISING THE SAME. | BAUSCH & LOMB (US) | 2017-03-01 | — | — | EP | claimed |
| CN-102460223-B | Biomedical devices | BAUSCH & LOMB | 2014-04-16 | — | — | CN | claimed |
| CN-102460223-A | Biomedical devices | BAUSCH & LOMB | 2012-05-16 | — | — | CN | claimed |
| EP-2443482-A2 | BIOMEDICAL DEVICES | Bausch & Lomb Incorporated (US) | 2012-04-25 | — | — | EP | claimed |
| WO-2010147864-A2 | BIOMEDICAL DEVICES | BAUSCH & LOMB INCORPORATED (US) | 2010-12-23 | — | — | WO | claimed |
| US-20100315588-A1 | Biomedical devices | BAUSCH & LOMB INCORPORATED (US) | 2010-12-16 | — | — | US | claimed |
| US-20260147141-A1 | SURFACE MODIFIED SILICONE OPHTHALMIC DEVICES | BAUSCH + LOMB IRELAND LIMITED (IE) | 2026-05-28 | — | — | US | disclosed |
| US-20260078209-A1 | SILICONE HYDROGEL INK BINDER FOR CONTACT LENSES | BAUSCH & LOMB IRELAND LTD (IE) | 2026-03-19 | — | — | US | disclosed |
| EP-4646240-A1 | BIOMEDICAL DEVICES HAVING A SURFACE COATING | Bausch + Lomb Ireland Limited (IE) | 2025-11-12 | — | — | EP | disclosed |
| US-20250321364-A1 | SURFACE MODIFIED OPHTHALMIC DEVICES | BAUSCH & LOMB IRELAND LTD (IE) | 2025-10-16 | — | — | US | disclosed |
| WO-2025215096-A1 | SILICONE CONTACT LENS-FORMING PREPOLYMER AND SILICONE CONTACT LENS FORMED THEREFROM | BAUSCH + LOMB IRELAND LIMITED (IE) | 2025-10-16 | — | — | WO | disclosed |
| CN-119907844-A | Adhesive composition and adhesive sheet | 株式会社力森诺科 | 2025-04-29 | — | — | CN | disclosed |
| US-20240240047-A1 | BIOMEDICAL DEVICES HAVING A SURFACE COATING | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2024-07-18 | — | — | US | disclosed |
| US-7625985-B1 | Water-based process for the preparation of polymer-clay nanocomposites | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2009-12-01 | — | — | US | disclosed |
| US-20070149709-A1 | S-benzyl-S'-(11-undecanoic acid) trithiocarbonate as free radical control agent; butadiene-styrene-vinylpyridine copolymer | GOODYEAR TIRE & RUBBER COMPANY, THE | 2007-06-28 | — | — | US | disclosed |
| US-20070149741-A1 | FUNCTIONAL TRITHIOCARBONATE RAFT AGENTS | GOODYEAR TIRE & RUBBER COMPANY, THE | 2007-06-28 | — | — | US | disclosed |
| EP-1801137-A1 | Surfactantless synthesis of amphiphilic cationic block copolymers | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2007-06-27 | — | — | EP | disclosed |
| EP-1801100-A1 | Functional trithiocarbonate RAFT agents | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2007-06-27 | — | — | EP | disclosed |
| EP-1801158-A1 | Water-based process for the preparation of polymer-clay nanocomposites | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2007-06-27 | — | — | EP | disclosed |
| US-7230063-B1 | Functional trithiocarbonate RAFT agents | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2007-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078209-A1 | SILICONE HYDROGEL INK BINDER FOR CONTACT LENSES | CRYAA, CRYAB, CRYZ | HDAC3 993/4885HDAC4 225/4885HDAC1 678/4885 |
| US-20260147141-A1 | SURFACE MODIFIED SILICONE OPHTHALMIC DEVICES | EPCAM, STIM1, SMCHD1 | HDAC3 1277/4885HDAC4 710/4885HDAC1 912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.